293 related articles for article (PubMed ID: 37165384)
41. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
42. Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity.
Lue Y; Gao C; Swerdloff R; Hoang J; Avetisyan R; Jia Y; Rao M; Ren S; Atienza V; Yu J; Zhang Y; Chen M; Song Y; Wang Y; Wang C
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H634-H643. PubMed ID: 29775411
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetic interaction between oltipraz and silymarin in rats.
Kang MK; Bae SK; Kim JW; Lee MG
J Pharm Pharm Sci; 2009; 12(1):1-16. PubMed ID: 19470289
[TBL] [Abstract][Full Text] [Related]
44. Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings.
Barış VÖ; Gedikli E; Yersal N; Müftüoğlu S; Erdem A
Amino Acids; 2019 Nov; 51(10-12):1649-1655. PubMed ID: 31673792
[TBL] [Abstract][Full Text] [Related]
45. The Effects of Mangiferin (Mangifera indica L) in Doxorubicin-induced Cardiotoxicity in Rats.
Arozal W; Suyatna FD; Juniantito V; Rosdiana DS; Amurugam S; Aulia R; Monayo ER; Siswandi R
Drug Res (Stuttg); 2015 Nov; 65(11):574-80. PubMed ID: 25426848
[TBL] [Abstract][Full Text] [Related]
46. The chemoprotective potentials of alpha-lipoic acid against cisplatin-induced ototoxicity: A systematic review.
Al-Awsi GRL; Arshed U; Arif A; Ramírez-Coronel AA; Alhassan MS; Mustafa YF; Rahman FF; Zabibah RS; Gupta J; Iqbal MS; Iswanto AH; Farhood B
Curr Med Chem; 2023 May; ():. PubMed ID: 37165582
[TBL] [Abstract][Full Text] [Related]
47. Cardioprotective effect of melatonin and agomelatine on doxorubicin-induced cardiotoxicity in a rat model: an electrocardiographic, scintigraphic and biochemical study.
Aygun H; Gul SS
Bratisl Lek Listy; 2019; 120(4):249-255. PubMed ID: 31023046
[TBL] [Abstract][Full Text] [Related]
48. A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities.
Moutabian H; Majdaeen M; Ghahramani-Asl R; Yadollahi M; Gharepapagh E; Ataei G; Falahatpour Z; Bagheri H; Farhood B
Cancer Cell Int; 2022 Apr; 22(1):142. PubMed ID: 35366874
[TBL] [Abstract][Full Text] [Related]
49. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
[TBL] [Abstract][Full Text] [Related]
50. Protective effect of silymarin against chemical-induced cardiotoxicity.
Razavi BM; Karimi G
Iran J Basic Med Sci; 2016 Sep; 19(9):916-923. PubMed ID: 27803777
[TBL] [Abstract][Full Text] [Related]
51. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.
Bryant J; Picot J; Levitt G; Sullivan I; Baxter L; Clegg A
Health Technol Assess; 2007 Jul; 11(27):iii, ix-x, 1-84. PubMed ID: 17610809
[TBL] [Abstract][Full Text] [Related]
52. Investigating in vitro anti-leishmanial effects of silibinin and silymarin on Leishmania major.
Faridnia R; Kalani H; Fakhar M; Akhtari J
Ann Parasitol; 2018; 64(1):29–35. PubMed ID: 29716183
[TBL] [Abstract][Full Text] [Related]
53. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.
Cufí S; Bonavia R; Vazquez-Martin A; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; Barrajón-Catalán E; Visa J; Segura-Carretero A; Bosch-Barrera J; Joven J; Micol V; Menendez JA
Food Chem Toxicol; 2013 Oct; 60():360-8. PubMed ID: 23916468
[TBL] [Abstract][Full Text] [Related]
54. Biochemical bases of the pharmacological action of the flavonoid silymarin and of its structural isomer silibinin.
Valenzuela A; Garrido A
Biol Res; 1994; 27(2):105-12. PubMed ID: 8640239
[TBL] [Abstract][Full Text] [Related]
55. The effects of different doses of silibinin in combination with methotrexate on testicular tissue of mice.
Oufi HG; Al-Shawi NN
Eur J Pharmacol; 2014 May; 730():36-40. PubMed ID: 24561045
[TBL] [Abstract][Full Text] [Related]
56. Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis.
Dhanalakshmi S; Mallikarjuna GU; Singh RP; Agarwal R
Carcinogenesis; 2004 Aug; 25(8):1459-65. PubMed ID: 15033902
[TBL] [Abstract][Full Text] [Related]
57. Liquiritigenin-Loaded Submicron Emulsion Protects Against Doxorubicin-Induced Cardiotoxicity via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activity.
Shi C; Wu H; Xu K; Cai T; Qin K; Wu L; Cai B
Int J Nanomedicine; 2020; 15():1101-1115. PubMed ID: 32110010
[TBL] [Abstract][Full Text] [Related]
58. Aspernolide F, as a new cardioprotective butyrolactone against doxorubicin-induced cardiotoxicity.
El-Agamy DS; Ibrahim SRM; Ahmed N; Khoshhal S; Abo-Haded HM; Elkablawy MA; Aljuhani N; Mohamed GA
Int Immunopharmacol; 2019 Jul; 72():429-436. PubMed ID: 31030099
[TBL] [Abstract][Full Text] [Related]
59. Silibinin potentially protects arsenic-induced oxidative hepatic dysfunction in rats.
Muthumani M; Prabu SM
Toxicol Mech Methods; 2012 May; 22(4):277-88. PubMed ID: 22229868
[TBL] [Abstract][Full Text] [Related]
60. Protective effects of silymarin against doxorubicin-induced toxicity.
Cecen E; Dost T; Culhaci N; Karul A; Ergur B; Birincioglu M
Asian Pac J Cancer Prev; 2011; 12(10):2697-704. PubMed ID: 22320977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
